WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a global clinical research organization in the design, development, and management of complex clinical trials and patient registries for many of the world’s leading pharmaceutical and biotechnology companies, announced today that it will issue its financial results for the second quarter of 2008 on Thursday, August, 14, 2008 after the close of the stock market, with an accompanying conference call on Friday, August, 15, 2008 at 11:00 A.M. ET.
